Concepedia
Statistics
Publications
7
Citations
324
H-Index
Active since
1968
Affiliations
Novartis (Switzerland)(Current)
Novartis (United States)
Novartis (United Kingdom)
Steve Maton is an author at Novartis (Switzerland) specializing in physiology, medicine, and pharmacology.
Top concepts
MedicinePhysiologyPharmacologyBiochemistryPharmacotherapyMetabolismClinical PharmacologyCardiovascular DiseaseMolecular PharmacologyCardiovascular Pharmacology
Publications per year
1968–2009
Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients
Gilbert Lefèvre, G Sędek, S. S. Jhee et al. · Clinical Pharmacology & Therapeutics · 2007 · 126 citations · Full text
The Passage of Vitamin C across the Erythrocyte Membrane
R. E. Hughes, Steve Maton · British Journal of Haematology · 1968 · 70 citations
Ascorbic Acid, Cell Physiology, Dehydroascorbic Acid +13
The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects
John M. Kovarik, Alan Slade, Gilles‐Jacques Rivière et al. · British Journal of Clinical Pharmacology · 2008 · 33 citations · Full text
Ketoconazole Increases Fingolimod Blood Levels in a Drug Interaction via CYP4F2 Inhibition
John M. Kovarik, Kiran Dole, Gilles‐Jacques Rivière et al. · The Journal of Clinical Pharmacology · 2009 · 30 citations
Healthy Subjects, Cyp4f2 Inhibition, Pharmacotherapy +19
Similar Rivastigmine Pharmacokinetics and Pharmacodynamics in Japanese and White Healthy Participants Following the Application of Novel Rivastigmine Patch
Gilbert Lefèvre, Monika Büche, G Sędek et al. · The Journal of Clinical Pharmacology · 2009 · 25 citations
1–5 of 7